PFE Stock Recent News Pfizer Inc (PFE) 28.41 08/05/2014 22:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 28.41 $PFE


Obama seeks executive ways to limit tax inversions
By JOSH LEDERMAN - AP - Tue Aug 05, 6:11PM CDT
WASHINGTON (AP) — Aiming to sidestep a logjam in Congress, the Obama administration is looking for steps it could take on its own to prevent American companies from reincorporating overseas to shirk U.S. taxes, officials said Tuesday.

Most active New York Stock Exchange-traded stocks
AP - Tue Aug 05, 5:06PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Tue Aug 05, 5:06PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

Drugmaker AstraZeneca Returns To Growth
at Investor's Business Daily - Tue Aug 05, 4:22PM CDT
British drugmaker AstraZeneca (AZN) has turned the corner after seeing its earnings fall for five straight quarters. In late July, the company delivered second-quarter earnings of $1.30 a share, up 8% from a year ago. Profit fell 17% to 28% in the...

Look for Shares of Pfizer to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Tue Aug 05, 3:47PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $28.29 to a high of $28.71. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.60 on volume of 27.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Pfizer to Potentially Rebound After Falling 1.18% Yesterday
Comtex SmarTrend(R) - Tue Aug 05, 3:47PM CDT
Pfizer (NYSEFE) traded in a range yesterday that spanned from a low of $28.29 to a high of $28.71. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.60 on volume of 27.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 2:00PM CDT
Zoetis (ZTS) missed the Zacks Consensus Estimate by a penny.

Midday Glance: Pharmaceuticals companies
AP - Tue Aug 05, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Dow: Investing Essentials
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Tue Aug 05, 9:53AM CDT
Credit : Rafael Matsunaga via Flickr . The Dow Jones Industrial Average , commonly known as "the Dow," is a price-weighted stock index of 30 leading U.S. companies, roughly two-thirds of which are manufacturers of industrial and consumer goods...

Early Glance: Pharmaceuticals companies
AP - Tue Aug 05, 9:40AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Next Support Level for Pfizer (PFE) is $28.41
Comtex SmarTrend(R) - Tue Aug 05, 9:29AM CDT
Shares of Pfizer (NYSEFE) have bearishly opened below the pivot of $28.77 today and have reached the first support level of $28.58. Analysts will be watching for a cross of the next downside pivot targets of $28.41 and $28.05.

Pain Therapeutics Reports Q2 2014 Financial Results
GlobeNewswire - Tue Aug 05, 8:01AM CDT
Pain Therapeutics, Inc. (NasdaqTIE) today reported financial results for Q2 2014. Net loss in Q2 2014 was $3.2 million, or $0.07 per share, compared to a net loss in Q2 2013 of $0.3 million, or $0.01 per share. Net cash used in Q2 2014 was $2.3 million. At June 30, 2014, cash and investments were $44.8 million. As previously disclosed, the Company believes net cash usage for 2014 may be approximately $12 million.

Johnson & Johnson Can Only Get Better When It Gets Cheaper
at The Street - Tue Aug 05, 5:00AM CDT
Income investors are waiting for the health products company to revisit $94, bringing the dividend yield back up to 3%.

Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer
PR Newswire - Mon Aug 04, 3:01PM CDT
Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of R. Scott Shively, as Chief Commercial Officer and Senior Vice President. Mr. Shively has extensive commercial leadership experience in sales and marketing of pain and neurology products, for both specialty as well as larger pharmaceutical companies.

Spin-Offs 101 And Value Creation
at The Street - Mon Aug 04, 2:40PM CDT
Spin-Offs: Why Do Companies Do It, And What They Might Mean To Your Portfolio William Hubbard, Benzinga Synchrony Financial (NYSE:SYF), also known as GE Capital, spun off on Thursday. Earlier in the w...

Dow 30 Stock Roundup: AmEx, XOM, PFE Beat on Earnings, CAT to Buy Back Shares - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Aug 04, 12:17PM CDT
The Dow had its worst week since Jan 24 last week.

Walgreen Names New CFO Ahead of Possible Inversion
at Investor's Business Daily - Mon Aug 04, 11:29AM CDT
Walgreen named former Kraft (KRFT) CFO Timothy McLevish as new EVP and CFO ahead of the national drugstore chain's decision on whether to acquire the rest of Alliance Boots. Shares of Walgreen (WAG) rose 1.4% to 71.52 on the stock market today....

American Express, Boeing, 5 Others Are Dragging Down the Dow 30
at The Street - Mon Aug 04, 11:14AM CDT
The Dow is still above its 200-day simple moving average but 12 components are not, and American Express, Boeing, GE, Coca Cola, McDonald's, Pfizer and United Technologies underperformed.

Rascal Flatts Joins the Thousands of People Who Choose Nexium(R) 24HR Every Day for Their Frequent Heartburn
Business Wire - Mon Aug 04, 7:00AM CDT
Pfizer Inc. (NYSEFE) announced today that the members of Rascal Flatts, the most-awarded country music band of the past decade, are among the thousands of people who choose Nexium(R) 24HR every day since becoming available without a prescription for frequent heartburn this past May.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 469

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 281

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 323

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 372

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 389

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 255

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 270

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Updates for Shareholders of Flywire and Others

Updated Category News Views 144

Key Investigations for Shareholders In recent developments, several corporations are facing legal scrutiny as investigations unfold concerning the fiduciary duties of their executives. This article aims to provide you with crucial information regarding these investigations. Flywire Corporation (NASDAQ: FLYW) Flywire Corporation (FLYW) is currently under the spotlight as...

Continue Reading
Jackbit Casino: A New Era of Instant Withdrawals for Players

Updated Category News Views 144

Jackbit Casino: Shaping the Future of Online Gambling The Canadian online casino landscape is undergoing significant transformation with a growing emphasis on privacy and instant access. As we delve into 2025, one platform stands out in this evolving market: Jackbit Casino. It has taken the lead by offering a unique gaming experience that prioritizes instant withdrawals...

Continue Reading
Schouw & Co. Updates on Share Buy-Back Program Progress

Updated Category News Views 115

Overview of the Share Buy-Back Program On May 5, 2025, Schouw & Co. took a significant step in its growth strategy by initiating a share buy-back program. This initiative, which was outlined in Company Announcement no. 20, aims to enhance shareholder value by acquiring shares up to a substantial limit of DKK 120 million. The program will run from May 5 until December 31,...

Continue Reading
2025 Wuzhen Summit: Future Visions for Digital Innovation

Updated Category News Views 390

2025 Wuzhen Summit and Its Significance The 2025 World Internet Conference (WIC) Wuzhen Summit has commenced, bringing together a diverse group of delegates from around the globe. This annually celebrated event serves as a pivotal platform for discussion on the future of the internet and digital technology. The summit emphasizes innovation and cooperation, as nations...

Continue Reading
Discover 'Inner Clarity': Your Path to Emotional Wellness

Updated Category News Views 170

Kirkus Lauds 'Inner Clarity' by David River Inner Clarity, the debut book by author David River, presents a structured framework aimed at helping individuals overcome limiting beliefs and achieve emotional well-being. The book is designed for anyone seeking to let go of inner constraints and embrace a more fulfilling self. Practical Insights for Personal Growth The book...

Continue Reading